506 related articles for article (PubMed ID: 34043963)
1. Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study.
Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Garland SM; Cornall AM; Atchison S; Hocking JS; Bradshaw CS; Balgovind P; Murray GL; Chen MY
Lancet Infect Dis; 2021 Oct; 21(10):1448-1457. PubMed ID: 34043963
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus Antibody Levels Following Vaccination or Natural Infection Among Young Men Who Have Sex With Men.
Chow EPF; Fairley CK; Zou H; Wigan R; Garland SM; Cornall AM; Atchison S; Tabrizi SN; Chen MY
Clin Infect Dis; 2022 Aug; 75(2):323-329. PubMed ID: 34971362
[TBL] [Abstract][Full Text] [Related]
3. Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study.
Zou H; Tabrizi SN; Grulich AE; Hocking JS; Bradshaw CS; Cornall AM; Morrow A; Prestage G; Law MG; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2015 Jan; 15(1):65-73. PubMed ID: 25435055
[TBL] [Abstract][Full Text] [Related]
4. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study.
Tabrizi SN; Brotherton JM; Kaldor JM; Skinner SR; Liu B; Bateson D; McNamee K; Garefalakis M; Phillips S; Cummins E; Malloy M; Garland SM
Lancet Infect Dis; 2014 Oct; 14(10):958-66. PubMed ID: 25107680
[TBL] [Abstract][Full Text] [Related]
5. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422
[TBL] [Abstract][Full Text] [Related]
6. Anal human papillomavirus among men who have sex with men in three metropolitan cities in southern China: implications for HPV vaccination.
Zhou Y; Lin YF; Meng X; Duan Q; Wang Z; Yang B; Zheng H; Li P; Li M; Lu Y; Luo Z; Zou H
Vaccine; 2020 Mar; 38(13):2849-2858. PubMed ID: 32088017
[TBL] [Abstract][Full Text] [Related]
7. HPV infections among young MSM visiting sexual health centers in the Netherlands: Opportunities for targeted HPV vaccination.
Woestenberg PJ; van Benthem BHB; Bogaards JA; King AJ; van der Klis FRM; Pasmans H; Leussink S; van der Sande MAB; Hoebe CJPA;
Vaccine; 2020 Apr; 38(17):3321-3329. PubMed ID: 32201140
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A
Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705
[TBL] [Abstract][Full Text] [Related]
9. Anal human papillomavirus infections in young unvaccinated men who have sex with men attending a sexual health clinic for HPV vaccination in Melbourne, Australia.
Chow EPF; Danielewski JA; Murray GL; Fehler G; Chen MY; Bradshaw CS; Garland SM; Fairley CK
Vaccine; 2019 Oct; 37(43):6271-6275. PubMed ID: 31521414
[TBL] [Abstract][Full Text] [Related]
10. Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men-United States, 2016-2018.
Meites E; Winer RL; Newcomb ME; Gorbach PM; Querec TD; Rudd J; Collins T; Lin J; Moore J; Remble T; Swanson F; Franz J; Bolan RK; Golden MR; Mustanski B; Crosby RA; Unger ER; Markowitz LE
J Infect Dis; 2020 Nov; 222(12):2052-2060. PubMed ID: 32504091
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies.
King EM; Gilson R; Beddows S; Soldan K; Panwar K; Young C; Prah P; Jit M; Edmunds WJ; Sonnenberg P
Br J Cancer; 2015 Apr; 112(9):1585-93. PubMed ID: 25791874
[TBL] [Abstract][Full Text] [Related]
12. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus.
Palefsky JM; Lensing SY; Belzer M; Lee J; Gaur AH; Mayer K; Futterman D; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Tirado M; Cachay ER; Barroso LF; Da Costa M; Darragh TM; Rudy BJ; Wilson CM; Kahn JA
Clin Infect Dis; 2021 Oct; 73(8):1388-1396. PubMed ID: 33991185
[TBL] [Abstract][Full Text] [Related]
13. Monitoring for Human Papillomavirus Vaccine Impact Among Gay, Bisexual, and Other Men Who Have Sex With Men-United States, 2012-2014.
Meites E; Gorbach PM; Gratzer B; Panicker G; Steinau M; Collins T; Parrish A; Randel C; McGrath M; Carrasco S; Moore J; Zaidi A; Braxton J; Kerndt PR; Unger ER; Crosby RA; Markowitz LE
J Infect Dis; 2016 Sep; 214(5):689-96. PubMed ID: 27296847
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Human Papillomavirus (HPV) Vaccination Against Penile HPV Infection in Men Who Have Sex With Men and Transgender Women.
Winer RL; Lin J; Querec TD; Unger ER; Stern JE; Rudd JM; Golden MR; Swanson F; Markowitz LE; Meites E
J Infect Dis; 2022 Feb; 225(3):422-430. PubMed ID: 34320185
[TBL] [Abstract][Full Text] [Related]
15. Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach.
Bogaards JA; Mooij SH; Xiridou M; Schim van der Loeff MF
PLoS Med; 2019 Mar; 16(3):e1002756. PubMed ID: 30830901
[TBL] [Abstract][Full Text] [Related]
16. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
Garland SM; Cornall AM; Brotherton JML; Wark JD; Malloy MJ; Tabrizi SN;
Vaccine; 2018 May; 36(23):3221-3230. PubMed ID: 29724506
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study.
Chow EP; Danielewski JA; Fehler G; Tabrizi SN; Law MG; Bradshaw CS; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2015 Nov; 15(11):1314-23. PubMed ID: 26201300
[TBL] [Abstract][Full Text] [Related]
18. Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials.
Mariz FC; Gray P; Bender N; Eriksson T; Kann H; Apter D; Paavonen J; Pajunen E; Prager KM; Sehr P; Surcel HM; Waterboer T; Müller M; Pawlita M; Lehtinen M
Lancet Infect Dis; 2021 Oct; 21(10):1458-1468. PubMed ID: 34081923
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017.
Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Regan DG; Hocking JS; Garland SM; Cornall AM; Atchison S; Bradshaw CS; McNulty A; Owen L; Marshall L; Russell DB; Kaldor JM; Chen MY
Vaccine; 2019 Oct; 37(46):6907-6914. PubMed ID: 31562001
[TBL] [Abstract][Full Text] [Related]
20. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men.
Videla S; Darwich L; Cañadas MP; Coll J; Piñol M; García-Cuyás F; Molina-Lopez RA; Cobarsi P; Clotet B; Sirera G;
Sex Transm Dis; 2013 Jan; 40(1):3-10. PubMed ID: 23250297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
